Lundbeckfonden Ventures

About The Fund

Lundbeckfonden Ventures is a specialized investment fund focusing on life science ventures, specifically within BioTech, HealthTech, Medical Devices, Investment Management, Life Sciences, and Oncology sectors. Established in the autumn of 2009, it is an evergreen capital structure wholly owned by the Lundbeck Foundation. Their approach is characterized by flexibility, allowing them to pursue a long-term perspective when appropriate, and to make strategic investments in groundbreaking life science companies. Annually, Lundbeckfonden Ventures commits up to 50 million euros to new ventures. The fund operates with a minimum investment threshold of 10 million and can invest up to a maximum of 327 million euros in its portfolio companies. They aim to generate financial returns that contribute to the foundation's broader activities and maintain its independence from the Lundbeck Foundation's controlling ownerships in H. Lundbeck A/S, ALK-Abell, and Falck. On their website, they emphasize key principles such as innovation, integrity, and sustainable growth. They seek to drive growth through expert analysis, build transformative partnerships, and optimize resources for better outcomes. The website highlights their commitment to life science innovation, showcasing vital data, success metrics, and client success stories. They express their team's expertise and dedication to advancing life sciences, supporting ventures from inception to success, and providing strategic insights, innovative partnerships, and resource optimization for the continued development of the industry. Their online presence extends to social platforms where they share insights and articles on life science innovations and venture capital investment.